Characterization of histamine releasing factors in diisocyanate-induced occupational asthma.
Immunologic mechanisms contributing to diisocyanate-induced occupational asthma (OA) are poorly defined. There is a relatively low incidence of diisocyanate-specific IgE antibody responses. The frequent occurrence of delayed onset asthmatic responses in workers with diisocyanate asthma suggests a role for cellular immune mechanisms. We have shown in vitro production of antigen-specific mononuclear cell-derived histamine releasing factors (HRF) by peripheral blood mononuclear cells (PBMCs) of workers with OA. Monocyte chemoattractant protein-1 (MCP-1) and RANTES (acronym for "regulated on activation normal T expressed and secreted") are chemokines found in PBMC supernatants that express HRF activity. Diisocyanate-exposed workers were tested for diisocyanate antigen-stimulated enhancement of HRF, MCP-1, and RANTES production in supernatants of PBMCs and for serum specific IgE and IgG antibody levels to diisocyanate antigens bound to human serum albumin (HSA). PBMCs of workers with diisocyanate OA showed significantly increased production of antigen-specific HRF activity and MCP-1 ( > 300 ng/ml) compared to diisocyanate-exposed asymptomatic workers (P < 0.05). Antigen-stimulated enhancement of MCP-1 mRNA was demonstrated by reverse-transcription PCR. RANTES mRNA and chemokine secretion ( < 1 ng/ml) was also demonstrated in PBMCs, but did not show antigen enhancement in OA workers. Hapten specificity for the diisocyanate chemical to which a patient had been exposed was demonstrated for HRF enhancement and for IgG antibody reactions, but not for IgE reactions. HRF production was demonstrated in PBMC subpopulations, including lymphocytes and purified T cells. OA subjects showed increased CD8+ cells by immunofluorescence (mean CD4+: CD8+ = 1.2 +/- 0.2). The results suggest that diisocyanate antigen enhancement of HRF and MCP-1 production are stimulated by hapten-specific T cell reactions. Since a weak association has been found between IgE antibody synthesis and induction of diisocyanate OA, the role of T cell cytokines and chemokines in the pathogenesis of OA requires further investigation.
Lummus
Z L
ZL
Department of Internal Medicine, University of Cincinnati College of Medicine, OH 45267-0563, USA.
Alam
R
R
Bernstein
J A
JA
Bernstein
D I
DI
D001249:Asthma / Q000139:chemically induced* / Q000276:immunology / Q000378:metabolism; D001483:Base Sequence; D014408:Biomarkers, Tumor; D000939:Epitopes / Q000032:analysis; D005260:Female; D006636:Histamine Release / Q000187:drug effects*; D006801:Humans; D017953:Isocyanates / Q000009:adverse effects* / Q000276:immunology; D007963:Leukocytes, Mononuclear / Q000145:classification / Q000276:immunology / Q000378:metabolism; D008222:Lymphokines / Q000096:biosynthesis / Q000737:chemistry* / Q000276:immunology; D008297:Male; D008969:Molecular Sequence Data; D009784:Occupational Diseases / Q000139:chemically induced* / Q000378:metabolism; D000090324:Tumor Protein, Translationally-Controlled 1
D014408:Biomarkers, Tumor; D000939:Epitopes; D017953:Isocyanates; D008222:Lymphokines; D000090324:Tumor Protein, Translationally-Controlled 1